LifeArc Chronic Respiratory Infection Translational Challenge is committing £3 million to support drug repurposing projects that seek to conduct translational studies, from proof of concept and preclinical studies through to clinical studies.
This forms part of LifeArc’s Translational Challenge in Chronic Respiratory Infection. This will follow-on from the £10 million funding call launched in Nov 2022.
Click here for more information.
